Evidence map›Paper›PMID 41458236›Full record

ArticleBMJ public health2025

Estimating the value of face coverings during the COVID-19 epidemic: a dynamic causal modelling study.

Cam Bowie, Anthony Costello, Karl Friston

Abstract read
In one paragraph

Article in BMJ public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Cam BowieSomerset Health Authority (retired), Axminster, UK.ORCID https://orcid.org/0000-0002-6956-3691
Anthony CostelloInstitute for Global Health, University College London, London, UK.ORCID https://orcid.org/0000-0002-0460-4245
Karl FristonQueen Square Institute of Neurology, University College London, London, UK.ORCID https://orcid.org/0000-0001-7984-8909

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The value of face coverings in the pandemic has been disputed. Dynamic causal modelling (DCM) allows one to test hypotheses about the nature of viral spread and effectiveness of interventions. Our aim was to quantify the impact of face coverings on viral transmission and deaths associated with COVID-19 between 2020 and 2023 in the UK. Methods: A DCM of the COVID-19 outbreak in the UK was used. It combines conventional (ie, Susceptible Exposed Infectious Recovered (SEIR)) epidemiological and sociobehavioural models to simultaneously fit measures of prevalence, clinical data, vaccine use and fluctuations in mobility. The model was augmented to include an effect of reported use of face coverings within the past week by adults in reducing community transmission, which was then suppressed to see what might have happened in their absence. Results: We found face coverings by adults reduced COVID-19 transmission by 5% in adults (90% CI 4.6% to 5.6%) and the elderly (90% CI 4.8% to 5.6%), but only by 2.3% in children (90% CI 1.5% to 3.4%) and had negligible effects in younger adults (0.4%, 90% CI 0.2% to 0.8%). This effect on transmission had a large impact on mortality, with an estimated saving of 102 000 (90% CI range 40 000 to 164 000) lives over the 30-month study period, suggesting a 50% reduction in mortality. Conclusions: Modelling the impact of widely used face coverings during the pandemic revealed a quantitatively small (age-dependent) impact on community transmission that translates into a marked public health impact, as estimated by the prevention of deaths.

Indexed as

Communicable Disease ControlCOVID-19EpidemiologyPublic Healthstatistics and numerical data

Identifiers

PMID41458236
PMCPMC12742113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.